ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Liyan Qiu

Liyan Qiu

Liyan Qiu
Professor
Zhejiang University
China
Tel: 86-571-882-08434

Zhejiang University

Biography

Liyan Qiu is a Professor & Director of Zhejiang University. She completed her Ph.D. from Zhejiang University on Polymer Chemistry and Physics. She started her career as an instructor and then as an Associate Professor in Zhejiang University. She has authored or co-authored more than 50 SCI-indexed papers on various international journals such as Journal of Controlled Release, Molecular Pharmaceutics, Nanomedicine, Biomaterials and so on. These papers have been cited by others for more than 530 times. She was selected into New Century Excellent Talents Program of China Ministry of Education and 151 Talents Program of Zhejiang Province, and awarded Chinese Pharmaceutical Association-CSPC young pharmaceutics award.

Research Interest

Research interests cover novel drug delivery systems and functional biomaterials used as drug carriers, specially controlled release preparations for peptide and protein drugs, targeted delivery system for anticancer drugs or genes, and self-assembly of amphiphilic biopolymers for drug delivery.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Rational Design of Synthetic Polymers as Drug Carriers for Cancer Therapy

Liyan Qiu
Editorial: J Mol Pharm Org Process Res 2013, 1:e101
DOI: 10.4172/2329-9053.1000e101
Relevant Topics
Top